164 related articles for article (PubMed ID: 35165061)
1. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of Type VII Collagen during oral carcinogenesis.
Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S
J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa.
Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT
Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189
[TBL] [Abstract][Full Text] [Related]
5. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
6. Histopathological assessment of oral leukoplakia. Osteonectin as possible biomarker for further diagnostics.
Duś-Ilnicka I; Radwan-Oczko M; Gerber H; Hałoń A
Pol J Pathol; 2020; 71(2):138-145. PubMed ID: 32729304
[TBL] [Abstract][Full Text] [Related]
7. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.
de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518
[TBL] [Abstract][Full Text] [Related]
8. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS
J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903
[TBL] [Abstract][Full Text] [Related]
9. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients.
Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L
Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174
[TBL] [Abstract][Full Text] [Related]
10. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
12. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
14. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
15. Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
de Carvalho Fraga CA; Farias LC; de Oliveira MV; Domingos PL; Pereira CS; Silva TF; Roy A; Gomez RS; de Paula AM; Guimarães AL
Pathol Res Pract; 2014 Dec; 210(12):959-64. PubMed ID: 25441661
[TBL] [Abstract][Full Text] [Related]
16. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Vijayakumar G; Narwal A; Kamboj M; Sen R
Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma.
Rahman R; Poomsawat S; Juengsomjit R; Buajeeb W
BMC Oral Health; 2019 Jul; 19(1):142. PubMed ID: 31291930
[TBL] [Abstract][Full Text] [Related]
18. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of p-Smad3 in oral carcinogenesis.
Poomsawat S; Punyasingh J; Vejchapipat P
Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]